Drugs / Metronomic Cyclophosphamide
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02117024 | Jul 2014 → Dec 2017 | non-small cell lung carcinoma | Heat Biologics | Terminated | Missed primary Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Metronomic Cyclophosphamide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02117024 ↗ |
| Route | Oral | “administered orally” NCT02117024 ↗ |